Therefore, the present study has further supported the concept that AGE-RAGE-ROS axis in the adipose tissues could be a therapeutic target for ameliorating impairment of adipocytokine profiles and insulin resistance in type 2 diabetes. Here, AGER is linked to type 2 diabetes mellitus.